Tyler Laszewski

1.2k total citations
6 papers, 560 citations indexed

About

Tyler Laszewski is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Tyler Laszewski has authored 6 papers receiving a total of 560 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 3 papers in Immunology and 2 papers in Molecular Biology. Recurrent topics in Tyler Laszewski's work include Immunotherapy and Immune Responses (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Cytokine Signaling Pathways and Interactions (1 paper). Tyler Laszewski is often cited by papers focused on Immunotherapy and Immune Responses (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Cytokine Signaling Pathways and Interactions (1 paper). Tyler Laszewski collaborates with scholars based in United States, Australia and United Kingdom. Tyler Laszewski's co-authors include Sandra S. McAllister, Molly J. DeCristo, Alex Toker, Whitney S. Henry, Tiffany Tsang, John N. Hutchinson, Jessalyn M. Ubellacker, Andrew H. Beck, Francisco Beça and Viviana Cremasco and has published in prestigious journals such as PLoS ONE, Nature Cell Biology and Cancer Research.

In The Last Decade

Tyler Laszewski

6 papers receiving 557 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tyler Laszewski United States	6	313	236	228	120	63	6	560
Touko Inao Japan	12	280 0.9×	184 0.8×	145 0.6×	106 0.9×	71 1.1×	20	495
Adeleye O. Adeshakin China	9	219 0.7×	267 1.1×	254 1.1×	164 1.4×	83 1.3×	19	552
Xinyun Xu China	11	183 0.6×	266 1.1×	199 0.9×	182 1.5×	39 0.6×	24	572
Yu‐zhong Duan China	12	320 1.0×	306 1.3×	263 1.2×	201 1.7×	107 1.7×	26	713
Mikako Nishida Japan	8	295 0.9×	394 1.7×	249 1.1×	165 1.4×	70 1.1×	12	689
Atsuko Ashida Japan	11	317 1.0×	330 1.4×	184 0.8×	139 1.2×	53 0.8×	29	636
Sophie de Carné Trécesson France	11	459 1.5×	422 1.8×	246 1.1×	117 1.0×	134 2.1×	12	836
Mary C. Weiser-Evans United States	14	310 1.0×	282 1.2×	372 1.6×	138 1.1×	133 2.1×	18	755

Countries citing papers authored by Tyler Laszewski

Since Specialization

Citations

This map shows the geographic impact of Tyler Laszewski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tyler Laszewski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tyler Laszewski more than expected).

Fields of papers citing papers by Tyler Laszewski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tyler Laszewski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tyler Laszewski. The network helps show where Tyler Laszewski may publish in the future.

Co-authorship network of co-authors of Tyler Laszewski

This figure shows the co-authorship network connecting the top 25 collaborators of Tyler Laszewski. A scholar is included among the top collaborators of Tyler Laszewski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tyler Laszewski. Tyler Laszewski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Jaiswal, Alok, Mukund Varma, Tyler Laszewski, et al.. (2022). Colon stroma mediates an inflammation-driven fibroblastic response controlling matrix remodeling and healing. PLoS Biology. 20(1). e3001532–e3001532. 63 indexed citations

2.

Sceneay, Jaclyn, Kristin Wilson, Sara Morrow, et al.. (2019). Interferon Signaling Is Diminished with Age and Is Associated with Immune Checkpoint Blockade Efficacy in Triple-Negative Breast Cancer. Cancer Discovery. 9(9). 1208–1227. 110 indexed citations

3.

Cremasco, Viviana, Jillian L. Astarita, Angelo L. Grauel, et al.. (2018). FAP Delineates Heterogeneous and Functionally Divergent Stromal Cells in Immune-Excluded Breast Tumors. Cancer Immunology Research. 6(12). 1472–1485. 147 indexed citations

4.

Castaño, Zafira, Beatriz P. San Juan, Asaf Spiegel, et al.. (2018). IL-1β inflammatory response driven by primary breast cancer prevents metastasis-initiating cell colonization. Nature Cell Biology. 20(9). 1084–1097. 130 indexed citations

5.

Qin, Yuanbo, et al.. (2018). Accounting for tumor heterogeneity when using CRISPR-Cas9 for cancer progression and drug sensitivity studies. PLoS ONE. 13(6). e0198790–e0198790. 7 indexed citations

6.

Henry, Whitney S., Tyler Laszewski, Tiffany Tsang, et al.. (2016). Aspirin Suppresses Growth in PI3K-Mutant Breast Cancer by Activating AMPK and Inhibiting mTORC1 Signaling. Cancer Research. 77(3). 790–801. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact